SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-008448
Filing Date
2023-03-16
Accepted
2023-03-16 16:07:16
Documents
13
Period of Report
2023-03-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sprb-20230316.htm   iXBRL 8-K 62828
2 EX-99.1 sprb-ex99_1.htm EX-99 255937
  Complete submission text file 0000950170-23-008448.txt   460973

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sprb-20230316.xsd EX-101.SCH 2501
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sprb-20230316_pre.xml EX-101.PRE 11578
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sprb-20230316_lab.xml EX-101.LAB 18527
7 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20230316_htm.xml XML 4901
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 23738807
SIC: 2834 Pharmaceutical Preparations